Breaking News

Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe

The sample-to-answer system is based on PCR technology and enables higher throughput than its Bruker predecessor.

Author Image

By: Patrick Lavery

Content Marketing Editor

Bruker announced its European launch of the MyGenius PRO molecular diagnostics system, based on polymerase chain reaction (PCR) technology. The announcement, in particular, comes from Bruker Corporation’s Microbiology & Infection Diagnostics division. Importantly, the system’s design focuses on infectious disease diagnostics. Assays Included in MyGenius PRO At launch, MyGenius PRO’s In Vitro Diagnostic Regulation (IVDR) menu includes assays for cytomegalovirus and Epstein-Barr vi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters